Holen Sie sich die Stockscreener-App
6.01
0.00%
0.00
Handel nachbörslich:
5.96
-0.05
-0.83%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MNKD?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$6.01
Offen:
$6.04
24-Stunden-Volumen:
3.39M
Relative Volume:
1.28
Marktkapitalisierung:
$1.66B
Einnahmen:
$248.37M
Nettoeinkommen (Verlust:
$11.74M
KGV:
120.20
EPS:
0.05
Netto-Cashflow:
$18.24M
1W Leistung:
-1.31%
1M Leistung:
+1.35%
6M Leistung:
+3.62%
1J Leistung:
+83.23%
1-Tages-Spanne:
$5.785
$6.04
1-Wochen-Bereich:
$5.785
$6.32
52-Wochen-Spanne:
$3.17
$7.63
Mannkind Corp Stock (MNKD) Company Profile
Firmenname
Mannkind Corp
Sektor
Branche
Telefon
818-661-5000
Adresse
1 CASPER STREET, DANBURY, CA
Vergleichen Sie MNKD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNKD
Mannkind Corp
|
6.01 | 1.66B | 248.37M | 11.74M | 18.24M | 0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Mannkind Corp Stock (MNKD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-12-19 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-10-10 | Eingeleitet | Wedbush | Outperform |
| 2021-05-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-24 | Eingeleitet | Oppenheimer | Outperform |
| 2019-10-25 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-05-14 | Eingeleitet | BTIG Research | Buy |
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
| 2019-02-22 | Eingeleitet | SVB Leerink | Outperform |
| 2018-02-28 | Herabstufung | Maxim Group | Hold → Sell |
| 2017-11-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2017-10-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-10-06 | Bestätigt | Maxim Group | Buy |
| 2017-08-11 | Eingeleitet | Maxim Group | Buy |
| 2016-05-10 | Bestätigt | Piper Jaffray | Underweight |
| 2016-05-10 | Bestätigt | RBC Capital Mkts | Underperform |
| 2016-01-06 | Bestätigt | Piper Jaffray | Underweight |
| 2016-01-06 | Bestätigt | RBC Capital Mkts | Underperform |
| 2015-11-04 | Herabstufung | RBC Capital Mkts | Outperform → Underperform |
| 2015-09-09 | Herabstufung | Piper Jaffray | Neutral → Underweight |
| 2015-08-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-05-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2015-05-11 | Bestätigt | MLV & Co | Hold |
| 2015-04-16 | Bestätigt | RBC Capital Mkts | Outperform |
Alle ansehen
Mannkind Corp Aktie (MNKD) Neueste Nachrichten
MannKind (NASDAQ:MNKD) Shares Down 3.1%Should You Sell? - MarketBeat
MannKind Co. (NASDAQ:MNKD) Sees Large Drop in Short Interest - MarketBeat
MannKind appoints new EVP as executive plans retirement - Investing.com
MannKind Expands Executive Leadership Team - Yahoo Finance
Here’s Why MannKind Corporation (NASDAQ:MNKD) Is Among the Best Diabetes Stocks to Buy Under $10 - Insider Monkey
10 Best Diabetes Stocks To Buy Under $10 - Insider Monkey
MNKDMannkind Corporation Latest Stock News & Market Updates - StockTitan
MannKind expecting to ‘practically double in size’ with new hires in Danbury - Westfair Online
MannKind Co. (NASDAQ:MNKD) Receives $8.88 Average PT from Analysts - MarketBeat
MannKind Co. (NASDAQ:MNKD) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Geode Capital Management LLC Has $39.88 Million Stock Holdings in MannKind Co. (NASDAQ:MNKD) - Defense World
MannKind Target of Unusually High Options Trading (NASDAQ:MNKD) - Defense World
MannKind (NASDAQ:MNKD) Stock Price Down 3.1%What's Next? - MarketBeat
Barclays PLC Buys 338,121 Shares of MannKind Co. (NASDAQ:MNKD) - Defense World
Barclays PLC Purchases 338,121 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
Exploring 3 High Growth Tech Stocks In The United States - Yahoo Finance
MannKind (NASDAQ:MNKD) Research Coverage Started at Wells Fargo & Company - Defense World
FY2025 EPS Estimates for MannKind Lowered by Leerink Partnrs - MarketBeat
Leerink Partnrs Decreases Earnings Estimates for MannKind - Defense World
Wells Fargo Initiates Coverage of MannKind (MNKD) with Overweight Recommendation - MSN
MannKind stock up 10% amid bullish Wells Fargo note - MSN
MannKind (NASDAQ:MNKD) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
MannKind (NASDAQ:MNKD) pulls back 3.8% this week, but still delivers shareholders fantastic 36% CAGR over 5 years - Yahoo Finance
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
RBC Capital Upgrades MannKind (MNKD) - MSN
MannKind (NASDAQ:MNKD) Trading Up 5.7%Here's Why - MarketBeat
3 High-Growth Biotech Stocks to Watch - Inkl
MannKind (NASDAQ:MNKD) Upgraded to Outperform at Royal Bank of Canada - MarketBeat
Tyvaso DPI royalties and pipeline potential boost MannKind stock—RBC - Investing.com
Noteworthy Wednesday Option Activity: MNKD, BTU, FSLR - Nasdaq
MannKind (NASDAQ:MNKD) Shares Gap UpShould You Buy? - MarketBeat
MannKind to issue shares in debt exchange deal - Investing.com
MannKind to issue shares in debt exchange deal By Investing.com - Investing.com Canada
MannKind trims debt with $194 million note exchange By Investing.com - Investing.com Canada
MannKind to reduce debt by 84% - MSN
MannKind trims debt with $194 million note exchange - Investing.com
MannKind Slashes Debt by 84% in Major Financial Restructuring, Converts $194M Notes to Equity - StockTitan
HighTower Advisors LLC Buys 107,560 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
MannKind (NASDAQ:MNKD) Stock Price Down 5.4%Here's Why - MarketBeat
MannKind Becomes Oversold (MNKD) - Nasdaq
Wellington Management Group LLP Acquires 85,977 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®) - Barchart
Mannkind Corp (MNKD-Q) QuotePress Release - The Globe and Mail
MannKind Announces Six-Month Results From Phase 3 - GlobeNewswire
The Manufacturers Life Insurance Company Grows Stake in MannKind Co. (NASDAQ:MNKD) - Defense World
Cipla’s ‘inhaled insulin’ from US’ MannKind Corp adds a ‘layer of convenience’ for those with diabetes - BusinessLine
CDSCO approves Cipla to distribute, market inhaled insulin in India - Daijiworld.com
CDSCO Approves Afrezza® (insulin human) Inhalation Powder in India - Yahoo Finance
Cipla gets CDSCO nod to launch inhalation insulin - The Economic Times
Two Sigma Advisers LP Buys 1,000,600 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
MannKind (NASDAQ:MNKD) Cut to "Hold" at StockNews.com - MarketBeat
Finanzdaten der Mannkind Corp-Aktie (MNKD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
4.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):